FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223524932> ?p ?o ?g. }

• W4223524932 endingPage "24" @default.
• W4223524932 startingPage "13" @default.
• W4223524932 abstract "•Despite advances with IDH1/2, FLT3, and BCL-2 directed therapies, treatment resistance and relapse remain frequent •Activating RAS mutations are associated with treatment resistance in targeted therapy for relapsed refractory AML •Significant clonal heterogeneity complicates relapse following targeted therapy •Mutational evolution as well as dysregulation of downstream signaling pathways, metabolism, and apoptosis all represent mechanisms of relapse following targeted therapy Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoiesis with a high rate of relapse and refractory disease despite intensive therapy. Traditionally, relapsed or refractory AML has increased therapeutic resistance and poor long-term survival. In recent years, advancements in the mechanistic understanding of leukemogenesis have allowed for the development of targeted therapies. These therapies offer novel alternatives to intensive chemotherapy and have prolonged survival in relapsed or refractory AML. Unfortunately, a significant portion of patients do not respond to these therapies and relapse occurs in most patients who initially responded. This review focuses on the mechanisms of resistance to targeted therapies in relapsed or refractory AML. Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoiesis with a high rate of relapse and refractory disease despite intensive therapy. Traditionally, relapsed or refractory AML has increased therapeutic resistance and poor long-term survival. In recent years, advancements in the mechanistic understanding of leukemogenesis have allowed for the development of targeted therapies. These therapies offer novel alternatives to intensive chemotherapy and have prolonged survival in relapsed or refractory AML. Unfortunately, a significant portion of patients do not respond to these therapies and relapse occurs in most patients who initially responded. This review focuses on the mechanisms of resistance to targeted therapies in relapsed or refractory AML." @default.
• W4223524932 created "2022-04-15" @default.
• W4223524932 creator A5051835784 @default.
• W4223524932 creator A5058878301 @default.
• W4223524932 date "2022-07-01" @default.
• W4223524932 modified "2023-10-09" @default.
• W4223524932 title "Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia" @default.
• W4223524932 cites W1503281372 @default.
• W4223524932 cites W1521952791 @default.
• W4223524932 cites W1643211657 @default.
• W4223524932 cites W1662899804 @default.
• W4223524932 cites W1965141098 @default.
• W4223524932 cites W1972903141 @default.
• W4223524932 cites W1983420428 @default.
• W4223524932 cites W1983641075 @default.
• W4223524932 cites W1984209370 @default.
• W4223524932 cites W1990992718 @default.
• W4223524932 cites W1995675594 @default.
• W4223524932 cites W2003067220 @default.
• W4223524932 cites W2005691176 @default.
• W4223524932 cites W2006640566 @default.
• W4223524932 cites W2008718421 @default.
• W4223524932 cites W2015507268 @default.
• W4223524932 cites W2017107901 @default.
• W4223524932 cites W2017349699 @default.
• W4223524932 cites W2034886137 @default.
• W4223524932 cites W2044088883 @default.
• W4223524932 cites W2047122678 @default.
• W4223524932 cites W2048369203 @default.
• W4223524932 cites W2048385227 @default.
• W4223524932 cites W2051815726 @default.
• W4223524932 cites W2052600649 @default.
• W4223524932 cites W2052690356 @default.
• W4223524932 cites W2056960087 @default.
• W4223524932 cites W2063441242 @default.
• W4223524932 cites W2063981273 @default.
• W4223524932 cites W2068962767 @default.
• W4223524932 cites W2073788073 @default.
• W4223524932 cites W2076830250 @default.
• W4223524932 cites W2083398319 @default.
• W4223524932 cites W2106206704 @default.
• W4223524932 cites W2113230030 @default.
• W4223524932 cites W2122659245 @default.
• W4223524932 cites W2125877707 @default.
• W4223524932 cites W2130008241 @default.
• W4223524932 cites W2134061682 @default.
• W4223524932 cites W2149941857 @default.
• W4223524932 cites W2153345005 @default.
• W4223524932 cites W2154313451 @default.
• W4223524932 cites W2154625299 @default.
• W4223524932 cites W2167251926 @default.
• W4223524932 cites W2171383975 @default.
• W4223524932 cites W2320463096 @default.
• W4223524932 cites W2343852802 @default.
• W4223524932 cites W2517675534 @default.
• W4223524932 cites W2526397866 @default.
• W4223524932 cites W2547060445 @default.
• W4223524932 cites W2584033231 @default.
• W4223524932 cites W2585860512 @default.
• W4223524932 cites W2588657480 @default.
• W4223524932 cites W2590604244 @default.
• W4223524932 cites W2613275252 @default.
• W4223524932 cites W2620653306 @default.
• W4223524932 cites W2623089849 @default.
• W4223524932 cites W2624245118 @default.
• W4223524932 cites W2625873300 @default.
• W4223524932 cites W2730666287 @default.
• W4223524932 cites W2740214316 @default.
• W4223524932 cites W2774533007 @default.
• W4223524932 cites W2776489049 @default.
• W4223524932 cites W2789326640 @default.
• W4223524932 cites W2793886497 @default.
• W4223524932 cites W2806009906 @default.
• W4223524932 cites W2806682325 @default.
• W4223524932 cites W2810336146 @default.
• W4223524932 cites W2884819478 @default.
• W4223524932 cites W2890015901 @default.
• W4223524932 cites W2891329755 @default.
• W4223524932 cites W2895480687 @default.
• W4223524932 cites W2899472109 @default.
• W4223524932 cites W2901585624 @default.
• W4223524932 cites W2902301444 @default.
• W4223524932 cites W2903860486 @default.
• W4223524932 cites W2904279482 @default.
• W4223524932 cites W2909346948 @default.
• W4223524932 cites W2910194312 @default.
• W4223524932 cites W2927792782 @default.
• W4223524932 cites W2942538710 @default.
• W4223524932 cites W2943489262 @default.
• W4223524932 cites W2945854417 @default.
• W4223524932 cites W2946259536 @default.
• W4223524932 cites W2948900598 @default.
• W4223524932 cites W2953821439 @default.
• W4223524932 cites W2963065975 @default.
• W4223524932 cites W2982353618 @default.
• W4223524932 cites W2982555809 @default.
• W4223524932 cites W2987733321 @default.
• W4223524932 cites W2994243335 @default.

• next